Gregory Downey - Oct 14, 2022 Form 4/A - Amendment Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Chief Financial Officer
Signature
/Gregory Downey/
Stock symbol
LEXX
Transactions as of
Oct 14, 2022
Transactions value $
$253
Form type
4/A - Amendment
Date filed
10/18/2022, 06:31 PM
Date Of Original Report
Oct 18, 2022
Previous filing
Aug 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Purchase $253 +121 +6.6% $2.09 1.95K Oct 14, 2022 Direct F1
holding LEXX common shares 1.83K Oct 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 4K Oct 14, 2022 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 8K Oct 14, 2022 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 12K Oct 14, 2022 Common Shares 4K $5.04 Direct
holding LEXX Stock Options 17K Oct 14, 2022 Common Shares 5K $5.31 Direct
holding LEXX Stock Options 25K Oct 14, 2022 Common Shares 8K $7.08 Direct
holding LEXX Stock Options 35K Oct 14, 2022 Common Shares 10K $6.23 Direct
holding LEXX Stock Options 46K Oct 14, 2022 Common Shares 11K $2.91 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4A is being filed to correct the transaction code for the open market purchase made by Mr. Downey as originally notated as a grant or award in the Form 4 filed on October 18, 2022.